Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 9
Submit an article Journal homepage
1,093
Views
7
CrossRef citations to date
0
Altmetric
Drug safety evaluation

Safety of dupilumab in patients with atopic dermatitis: expert opinion

Wojciech FrancuzikDiv. Allergy and Immunology, Department of Dermatology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, GermanyView further author information
,
Aikaterina AlexiouDiv. Allergy and Immunology, Department of Dermatology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, GermanyView further author information
&
Margitta WormDiv. Allergy and Immunology, Department of Dermatology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, GermanyCorrespondence[email protected]
View further author information
Pages 997-1004 | Received 09 Apr 2021, Accepted 03 Jun 2021, Published online: 19 Jun 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shiyu Zhang, Lu Lu, Jindi Feng, Zhonghui Hu, Hongbin Song, Lu Yang, Yuehua Liu, Di Chen & Tao Wang. (2023) Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient. Journal of Dermatological Treatment 34:1.
Read now

Articles from other publishers (6)

D. N. Adam, M. J. Gooderham, J. R. Beecker, C. H. Hong, C. S. Jack, V. Jain, P. Lansang, C. W. Lynde, K. A. Papp, V. H. Prajapati, I. Turchin & J. Yeung. (2023) Expert consensus on the systemic treatment of atopic dermatitis in special populations. Journal of the European Academy of Dermatology and Venereology 37:6, pages 1135-1148.
Crossref
Tomas Mickevicius, Andrew E. Pink, Maninder Bhogal, David O'Brart & Scott J. Robbie. (2023) Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Management. Cornea 42:4, pages 507-519.
Crossref
Erin Boh, Drew Kuraitis, Abby Jacobson & Martha Sikes. (2023) Healthcare Provider Experience in Diagnosing and Treating Cutaneous T-Cell Lymphoma. Dermatology and Therapy 13:3, pages 835-842.
Crossref
Peter D. Arkwright & Jennifer J. Koplin. (2023) Impact of a Decade of Research Into Atopic Dermatitis. The Journal of Allergy and Clinical Immunology: In Practice 11:1, pages 63-71.
Crossref
YunMi Qiu, Kamran Ali, HaiYue Lou, JingPeng Shan & Liming Wu. (2022) Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin’s Lymphoma. Acta Dermato-Venereologica 102, pages adv00625.
Crossref
Karol Kołkowski, Magdalena Trzeciak & Małgorzata Sokołowska-Wojdyło. (2021) Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas. International Journal of Molecular Sciences 22:24, pages 13388.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.